PERFOROMIST

LOE Approaching

formoterol fumarate dihydrate

NDAINHALATIONSOLUTION
Approved
May 2007
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
2

Mechanism of Action

long-acting, beta 2 -adrenergic receptor agonist (beta 2 -agonist). Inhaled formoterol fumarate acts locally in the lung as a bronchodilator. In vitro studies have shown that formoterol has more than 200-fold greater agonist activity at beta 2 -receptors than at beta 1 -receptors. Although beta 2…

Clinical Trials (2)

NCT03181880Phase 4Withdrawn

To Evaluate Effectiveness of Aclidinium Bromide/Formoterol Fumarate Dihydrate in Chronic Obstructive Pulmonary Disease

Started Dec 2017
0
Chronic Obstructive Pulmonary Disease
NCT02495168Phase 3Completed

Randomized, Placebo-Controlled, Multidose, Study Comparing Generic Budesonide/Formoterol Fumarate Dihydrate to Symbicort® in Asthmatic Participants

Started Jan 2017
1,714 enrolled
Asthma